Tae Kyo Park

Tae Kyo Park

Company: Intocell

Job title: Chief Executive Officer


Application of OHPAS Linker to B7H3 ADC 12:00 pm

• Review IntoCell’s OHPAS linker platform technology • Evaluate the concept of IntoCell’s drug modification approach to improve therapeutic index • Discuss ITC-6146RO, a preclinical candidate in IntoCell’s B7H3 ADC ProgramRead more

day: day 2 track 1

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.